^




    Show legend
    Group by Gene:
    Include preclinical:

    nivolumab
    pembrolizumab
    		0
    PD1 inhibitor
    toripalimab-tpzi
    pucotenlimab
    PD1 inhibitor
    nivolumab + ipilimumab
    		1
    PD1 inhibitor, CTLA4 inhibitor
    pembrolizumab + ipilimumab
    ipilimumab biosimilar (CS1002) + CS1003
    PD1 inhibitor + CTLA4 inhibitor
    2
    CTLA4 inhibitor
    ipilimumab
    CTLA4 inhibitor
    temozolomide
    dacarbazine
    		3
    DNA synthesis inhibitor
    cisplatin + dacarbazine
    cisplatin + temozolomide
    cisplatin
    trametinib
    selumetinib
    CH4987655
    binimetinib
    		4
    MEK inhibitor
    AS703026
    PD-0325901
    CI-1040
    DS03090629
    MEK inhibitor
    5
    ALK inhibitor
    crizotinib
    ceritinib
    dabrafenib
    GDC 0879
    PLX4720
    		6
    BRAF inhibitor
    ABM-1310
    PF-07284890
    SB-590885
    BRAF inhibitor
    nivolumab / relatlimab
    		7
    PD1 inhibitor, LAG-3 inhibitor
    cemiplimab-rwlc + REGN3767
    PD1 inhibitor + LAG-3 inhibitor
    8
    BRAF inhibitor, BRAF V600E inhibitor
    vemurafenib
    FORE-8394
    9
    GM-CSF agonist
    talimogene laherparepvec
    ONCOS-102
    10
    PD1 inhibitor, BRAF inhibitor
    pembrolizumab + dabrafenib
    PD1 inhibitor + BRAF inhibitor
    11
    GM-CSF agonist, CTLA4 inhibitor
    ipilimumab + talimogene laherparepvec
    12
    Bcl2 inhibitor, Tubulin inhibitor
    albumin-bound paclitaxel
    trametinib + dabrafenib
    		13
    MEK inhibitor, BRAF inhibitor
    dabrafenib + DS03090629
    PD-0325901 + BGB-3245
    BRAF inhibitor + MEK inhibitor
    14
    VEGFR-2 inhibitor, PD1 inhibitor
    camrelizumab + rivoceranib
    BVD-523
    		15
    ERK2 inhibitor, ERK1 inhibitor
    LY3214996
    JSI-1187
    ASN007
    tovorafenib
    		16
    pan-RAF inhibitor
    KIN-2787
    LY3009120
    RG6185
    atezolizumab
    		17
    PD-L1 inhibitor
    durvalumab
    avelumab
    PD-L1 inhibitor
    18
    pan-RAF inhibitor, MEK1 inhibitor
    cobimetinib + RG6185
    19
    HDAC inhibitor
    vorinostat
    20
    Multi-tyrosine kinase inhibitor
    regorafenib
    MGCD516
    palbociclib
    		21
    CDK4 inhibitor, CDK6 inhibitor
    dalpiciclib
    ribociclib
    abemaciclib
    22
    PD1 inhibitor, IDO1 inhibitor
    pembrolizumab + INCB024360
    nivolumab + BMS-986205
    23
    VEGFR-2 inhibitor, DNA synthesis inhibitor
    temozolomide + rivoceranib
    24
    IFNα 2b stimulant
    interferon α-2b
    25
    Bcr-abl tyrosine kinase inhibitor
    nilotinib
    26
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    larotrectinib
    27
    IL-2R agonist
    ALKS 4230
    28
    Immunostimulant, Dendritic cell activator
    PVS-RIPO
    29
    Immunostimulant, PD1 inhibitor
    pembrolizumab + EVX-01
    30
    PD1 inhibitor, IDO inhibitor
    pembrolizumab + NLG8189
    nivolumab + NLG8189
    31
    MEK1 inhibitor
    cobimetinib
    cobimetinib
    32
    VEGF-A inhibitor
    bevacizumab
    33
    STAB1 inhibitor
    bexmarilimab
    34
    PD1 inhibitor, BRAF inhibitor, BRAF V600E inhibitor
    pembrolizumab + vemurafenib
    vemurafenib + toripalimab-tpzi
    35
    ALK inhibitor, BRAF inhibitor, BRAF V600E inhibitor
    crizotinib + vemurafenib
    36
    ATR inhibitor
    AZD6738
    37
    HER2 inhibitor, HER2 dimerization inhibitor
    trastuzumab + pertuzumab
    38
    VEGFR inhibitor, PD1 inhibitor
    toripalimab-tpzi + axitinib
    39
    GSK3β inhibitor
    9-ING-41
    40
    MEK inhibitor, MDM2 inhibitor
    trametinib + KRT-232
    41
    PI3K inhibitor
    GDC-0941
    AN2025
    42
    TIGIT inhibitor
    EOS-448
    43
    Hedgehog cell-signalling pathway inhibitor
    vismodegib
    44
    MAGE-A3 modulator
    MAGE-A3 vaccine
    45
    PI3Kβ inhibitor, PD1 inhibitor
    pembrolizumab + GSK2636771
    46
    KRAS G12C inhibitor
    sotorasib
    47
    gp100 inhibitor
    tebentafusp-tebn
    48
    DNA synthesis inhibitor, PD1 inhibitor
    nivolumab + temozolomide
    49
    PRMT5 inhibitor
    MRTX1719
    50
    PD1 inhibitor, PARP inhibitor
    nivolumab + olaparib
    51
    PD-L1 inhibitor, BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
    atezolizumab + vemurafenib + cobimetinib
    52
    pan-RAF inhibitor, Multi-tyrosine kinase inhibitor
    sorafenib
    53
    TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
    entrectinib
    trametinib + dabrafenib + PDR001
    		54
    PD1 inhibitor, MEK inhibitor, BRAF inhibitor
    pembrolizumab + trametinib + dabrafenib
    nivolumab + trametinib + dabrafenib
    PD1 inhibitor + BRAF inhibitor + MEK inhibitor
    55
    PDGFR inhibitor, Bcr-abl tyrosine kinase inhibitor, c-KIT inhibitor
    imatinib
    56
    PD1 inhibitor, MEK inhibitor
    pembrolizumab + trametinib
    PD1 inhibitor + MEK inhibitor
    57
    Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel
    58
    FGFR inhibitor, VEGFR inhibitor, RET inhibitor, PD1 inhibitor, c-KIT inhibitor, PDGFR α antagonist
    pembrolizumab + lenvatinib
    59
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor, Tubulin inhibitor
    paclitaxel + albumin-bound paclitaxel + dacarbazine
    60
    CD122 agonist, IL-2 stimulant
    aldesleukin
    61
    TLR7 agonist, TLR8 agonist
    imiquimod
    62
    PD1 inhibitor, GM-CSF agonist
    PD1 inhibitor + talimogene laherparepvec
    63
    BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
    vemurafenib + cobimetinib
    64
    MEK inhibitor, MEK2 inhibitor, MEK1 inhibitor
    HL-085
    65
    cRAF inhibitor, BRAF inhibitor
    encorafenib
    RAF709
    66
    cRAF inhibitor, MEK inhibitor, BRAF inhibitor
    binimetinib + encorafenib
    trametinib + encorafenib
    67
    PDGFR β inhibitor, PDGFR α inhibitor, FLT3 inhibitor
    ARO-002
    68
    CD40 agonist, TLR4 antagonist, CD70 inhibitor
    ex-vivo autologous dendritic cells vaccine
    69
    Bcr-abl tyrosine kinase inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib
    70
    TLR9 agonist, PD1 inhibitor, Immunomodulator
    nivolumab + CMP-001
    pembrolizumab + CMP-001
    71
    PD-L1 inhibitor, MEK1 inhibitor
    atezolizumab + cobimetinib
    72
    pan-RAF inhibitor, cRAF inhibitor, MEK inhibitor, BRAF inhibitor
    trametinib + ERAS-254
    73
    VEGFR inhibitor, PDGFR inhibitor, c-KIT inhibitor
    sunitinib
    74
    Immunostimulant, MAGE-A3 inhibitor, Protein tyrosine phosphatase inhibitor, Tyrosinase inhibitor, NY ESO 1 inhibitor
    BNT111
    75
    pan-RAF inhibitor, EGFR inhibitor
    BGB-283
    cetuximab + BGB659
    76
    CDK4 inhibitor, BRAF inhibitor, CDK6 inhibitor, BRAF V600E inhibitor
    palbociclib + vemurafenib
    77
    Alkylating agent, DNA synthesis inhibitor
    fotemustine
    78
    MEK inhibitor, BRAF inhibitor, CSF-1 inhibitor
    trametinib + dabrafenib + MCS110
    79
    PD1 inhibitor, BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
    pembrolizumab + vemurafenib + cobimetinib
    80
    PD-L1 inhibitor, PD1 inhibitor, IDO inhibitor
    nivolumab + IO102-IO103
    81
    PDGFR α inhibitor, c-KIT inhibitor, FLT3 inhibitor
    ripretinib
    FCN-159
    		82
    MEK2 inhibitor, MEK1 inhibitor
    REC-4881
    U0126
    83
    T lymphocyte replacement, Immunostimulant
    lifileucel
    84
    cRAF inhibitor, PD1 inhibitor, MEK inhibitor, BRAF inhibitor
    pembrolizumab + binimetinib + encorafenib
    85
    Microtubule stabilizer, Tubulin polymerization promoter, Sortilin inhibitor
    TH 1902
    86
    MAP4K2 inhibitor, TAK1 inhibitor
    TL-1-85
    87
    PDGFR inhibitor, Bcr-abl tyrosine kinase inhibitor, PD1 inhibitor, c-KIT inhibitor
    imatinib + toripalimab-tpzi
    88
    PD-L1 inhibitor, gp100 inhibitor, CTLA4 inhibitor
    durvalumab + tremelimumab + tebentafusp-tebn
    89
    BRAF inhibitor, BRAF V600E inhibitor, Cytochrome P450 inhibitor
    FORE-8394 + cobicistat
    90
    PD-L1 inhibitor, MEK inhibitor, BRAF inhibitor
    trametinib + dabrafenib + durvalumab
    91
    cRAF inhibitor, PD1 inhibitor, MEK inhibitor, BRAF inhibitor, CTLA4 inhibitor
    nivolumab + ipilimumab + binimetinib + encorafenib
    92
    PD-L1 inhibitor, Immunostimulant
    atezolizumab + RG6180
    93
    pan-RAF inhibitor, VEGF-A inhibitor, mTOR inhibitor, Multi-tyrosine kinase inhibitor
    bevacizumab + sorafenib + temsirolimus
    94
    HSP90 inhibitor, BRAF inhibitor, BRAF V600E inhibitor
    vemurafenib + XL888
    95
    HDAC inhibitor, HDAC1 inhibitor, PD1 inhibitor, LSD1 inhibitor, HDAC2 inhibitor, HDAC3 inhibitor
    nivolumab + 4SC-202
    96
    pan-RAF inhibitor, cRAF inhibitor, PD1 inhibitor, BRAF inhibitor
    PDR001 + ERAS-254
    binimetinib + ribociclib
    		97
    CDK4 inhibitor, MEK inhibitor, CDK6 inhibitor
    trametinib + palbociclib
    palbociclib + binimetinib
    MEK inhibitor + CDK4 inhibitor + CDK6 inhibitor
    98
    BRAF inhibitor, MDM2 inhibitor
    dabrafenib + KRT-232
    99
    PD-L1 inhibitor, MEK inhibitor
    trametinib + durvalumab
    100
    CD137 agonist, HER2 inhibitor
    PRS-343
    101
    MEK inhibitor, BRAF inhibitor, MDM2 inhibitor
    trametinib + dabrafenib + KRT-232
    102
    PD-L1 inhibitor, gp100 inhibitor
    durvalumab + tebentafusp-tebn
    103
    MEK inhibitor, PI3K inhibitor, mTOR inhibitor
    selumetinib + RTB101
    trametinib + GSK2126458
    104
    AMPK activator, MEK inhibitor, mTOR inhibitor, BRAF inhibitor
    trametinib + dabrafenib + phenformin
    105
    FGFR inhibitor, VEGFR inhibitor, RET inhibitor, BRAF inhibitor, c-KIT inhibitor, PDGFR α antagonist
    dabrafenib + lenvatinib
    106
    PDGFR antagonist, mutant c-KIT inhibitor, CSF-1R inhibitor
    avapritinib
    107
    MEK inhibitor, BRAF inhibitor, Bcl2 inhibitor, Bcl-xL inhibitor, Bcl-w inhibitor
    trametinib + dabrafenib + ABT 263
    108
    HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    ado-trastuzumab emtansine
    109
    HER2 inhibitor, EGFR inhibitor
    lapatinib
    110
    PI3K inhibitor, mTOR inhibitor, AKT inhibitor
    GDC-0084
    111
    pan-RAF inhibitor, DDR inhibitor
    PHI-501
    112
    PKC inhibitor
    IDE196
    113
    AKT inhibitor
    capivasertib
    MK-2206
    114
    PI3Kγ inhibitor, PI3Kδ inhibitor
    duvelisib
    115
    BRAF inhibitor, AKT inhibitor
    dabrafenib + LAE003
    116
    pan-RAF inhibitor, SRC-family kinase (SFK) inhibitor
    CCT241161 + CCT196969
    CCT241161
    117
    CDK4 inhibitor, PI3K inhibitor, mTOR inhibitor, CDK6 inhibitor, WEE1 inhibitor
    palbociclib + AZD1775 + PI-103
    118
    ATR inhibitor, PARP inhibitor
    olaparib + AZD6738
    119
    EZH2 inhibitor
    GSK2816126
    JQEZ5
    120
    pan-RAF inhibitor, MEK inhibitor, EGFR inhibitor
    PD-0325901 + BGB-283
    121
    RET inhibitor, FLT3 inhibitor
    AST-487
    122
    IDH1 inhibitor
    ivosidenib
    123
    cRAF inhibitor, BRAF inhibitor, BRAF V600E inhibitor
    encorafenib + FORE-8394
    vemurafenib + dabrafenib + encorafenib
    124
    T-cell stimulant, CD27 agonist, PD1 inhibitor
    nivolumab + CDX 1127
    binimetinib + KIN-2787
    		125
    pan-RAF inhibitor, MEK inhibitor
    trametinib + LY3009120
    trametinib + AZ 628
    MEK inhibitor + pan-RAF inhibitor
    126
    HDAC inhibitor, MEK inhibitor
    binimetinib + OKI-179
    127
    HDAC inhibitor, cRAF inhibitor, BRAF inhibitor
    encorafenib + OKI-179
    128
    PIK3CA inhibitor, BRAF inhibitor
    dabrafenib + alpelisib
    129
    PIK3CA inhibitor, MEK inhibitor
    trametinib + alpelisib
    130
    AXL inhibitor, BRAF inhibitor, BRAF V600E inhibitor
    vemurafenib + BGB324
    131
    AXL inhibitor
    BGB324
    132
    KRAS G12C inhibitor, MEK2 inhibitor, MEK1 inhibitor
    sotorasib + IMM-1-104
    133
    Alkylating agent
    lomustine
    chlorambucil
    134
    DDX5 degrader
    FL118
    135
    mTOR inhibitor, PDK1 inhibitor
    everolimus + dichloroacetate topical
    136
    EZH1 inhibitor, EZH2 inhibitor
    UNC1999
    137
    DNA synthesis inhibitor, PD1 inhibitor, MEK inhibitor, CTLA4 inhibitor
    pembrolizumab + nivolumab + trametinib + ipilimumab + dacarbazine
    138
    DNA methylation inhibitor
    TdCyd
    139
    MCL1 inhibitor, cRAF inhibitor, BRAF inhibitor
    encorafenib + S63845
    140
    WEE1 inhibitor
    AZD1775
    141
    pan-RAF inhibitor, PD-L1 inhibitor
    atezolizumab + RG6185
    142
    PI3Kβ inhibitor, OX40 ligand inhibitor
    GSK2636771 + ENUM004
    SCH772984
    		143
    ERK inhibitor
    DEL-22379
    KO-947
    144
    MEK inhibitor, TAK1 inhibitor
    trametinib + EDHS-206
    145
    c-KIT inhibitor
    MP470
    146
    MERTK inhibitor, FLT3 inhibitor
    UNC2025
    147
    PI3K inhibitor, FAK inhibitor, AKT inhibitor
    LY294002
    148
    PI3K inhibitor, mTOR inhibitor
    RTB101
    149
    BET inhibitor
    JQ-1
    150
    eIF4G1 inhibitor, NF-κB inhibitor, mTORC1 inhibitor, AKT inhibitor
    SBI-726
    SBI-756
    151
    HER3-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    U3-1402
    152
    BRAF inhibitor, BRAF V600E inhibitor, AKT inhibitor
    vemurafenib + MK-2206
    153
    pan-RAF inhibitor, Apoptosis inducer, PP2A activator, Multi-tyrosine kinase inhibitor
    sorafenib + nanoliposomal ceramide
    154
    MAP3K1 inhibitor, ACVR1 inhibitor, MEK2 inhibitor, MEK1 inhibitor, FLT3 inhibitor
    E6201
    155
    MDM2 inhibitor
    KRT-232
    156
    PFKFB3 inhibitor
    3PO
    157
    ERK2 inhibitor
    VTX-11e
    158
    MERTK-targeted antibody-drug conjugate
    RGX-019
    159
    PARP inhibitor, ATM kinase inhibitor
    talazoparib + KU-55933
    160
    CAR-T immunotherapy
    AMT-253
    161
    HLA-DR-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    IMMU-140
    162
    CDK inhibitor
    MK-7965
    163
    PI3K inhibitor, PI3Kγ inhibitor, BRAF V600E inhibitor, PI3Kδ inhibitor
    CB-006-3
    164
    Topoisomerase II inhibitor
    doxorubicin hydrochloride
    165
    mTOR inhibitor
    temsirolimus
    166
    Aurora kinase B inhibitor, BRAF inhibitor
    HI-511
    167
    IDH1 inhibitor, BRAF inhibitor
    dabrafenib + ivosidenib
    168
    MEK inhibitor, AKT inhibitor
    selumetinib + MK-2206
    169
    HSP90 inhibitor
    XL888
    170
    Microtubule inhibitor, CD228-targeted antibody-drug conjugate
    SGN-CD228A
    171
    pan-RAF inhibitor, MEK inhibitor, Multi-tyrosine kinase inhibitor
    trametinib + sorafenib
    172
    JAK2 inhibitor, FLT3 inhibitor
    fedratinib
    173
    JAK1 inhibitor, JAK2 inhibitor
    ruxolitinib
    174
    CDC42 inhibitor
    ARN22089
    175
    EZH2 inhibitor, BRAF inhibitor
    dabrafenib + JQEZ5
    176
    STING agonist
    CS-1018
    177
    MERTK inhibitor, MEK1 inhibitor, FLT3 inhibitor
    cobimetinib + UNC2025
    178
    SRC-family kinase (SFK) inhibitor
    SAB298
    179
    MEK inhibitor, TYRP1 inhibitor
    MEK inhibitor + TA99
    180
    Immunotherapy
    Immunotherapy
    181
    PD-L1 inhibitor, CTLA4 inhibitor
    PD-L1 inhibitor + CTLA4 inhibitor
    182
    PD-L1 inhibitor, PD1 inhibitor
    PD1 inhibitor + PD-L1 inhibitor
    CVD
    		183
    Chemotherapy
    CaT
    TC
    184
    PLK1 inhibitor, BRAF inhibitor
    BRAF inhibitor + PLK1 inhibitor
    185
    STAT3 inhibitor, PD1 inhibitor
    PD1 inhibitor + STAT3 inhibitor
    186
    T-lymphocyte cell therapy
    T-lymphocyte cell therapy
    No biomarker
    BRAF V600
    BRAF mutation
    BRAF V600E
    BRAF wild-type
    BRAF fusion
    BRAF V600K
    BRAF L597K
    BRAF V600D
    BRAF K601E
    BRAF L597Q
    BRAF V600M
    BRAF L597R
    BRAF L597S
    BRAF V600DK601del
    BRAF V600E + BRAF V600K
    BRAF V600 wild-type
    BRAF positive
    BRAF V600G
    BRAF V600R
    BRAF G469S
    BRAF D594G
    BRAF amplification
    BRAF G464E
    BRAF L505H
    BRAF rearrangement
    BRAF D549G
    BRAF G469E
    BRAF T1799A
    NRAS mutation
    NRAS Q61L
    NRAS Q60H
    NRAS Q61H
    NRAS G12D
    NRAS G12S
    NRAS wild-type
    NRAS G13R
    NRAS Q61
    NRAS Q61K
    NRAS Q61R
    NRAS G13D
    NRAS A146T
    NRAS overexpression
    NRAS amplification
    TMB-H
    TMB-L
    KIT mutation
    KIT wild-type
    KIT exon 13 mutation
    KIT L576
    KIT translocation
    KIT exon 17 mutation
    KIT K642E
    KIT amplification
    KIT exon 11 mutation
    KIT V559A + KIT N822I
    KIT fusion
    KIT L576P
    KIT S628N
    KIT V559D
    KIT T670I
    KIT A829P
    KIT D820Y
    KIT overexpression
    PD-L1 expression
    PD-L1 overexpression
    PD-L1 negative
    PD-L1 underexpression
    PD-L1 elevation
    ROS1 fusion
    ALK fusion
    ALK mutation
    TMB-H + LDH elevation
    TMB-L + LDH elevation
    CCND1 amplification
    KRAS amplification
    MAP2K1 F53Y
    MAP2K1 P124S
    MAP2K1 mutation
    KRAS mutation
    KRAS G12C
    MAP2K1 G276W
    CCND1 underexpression
    MAP2K1 C125S
    MAP2K1 P124
    MAP2K1 P124L
    MAP2K1 V60E
    MAP2K1 P124Q
    MAP2K1 K57N
    MAP2K1 G128V
    MAP2K1 C121S
    MAP2K1 V154I
    MAP2K1 Q56P
    MAP2K1 K59del
    MAP2K1 S218D + MAP2K1 S222D
    MAP2K1 F129L
    KRAS G13D overexpression
    KRAS overexpression
    MAP2K1 K57E
    MAP2K1 E203K
    BRAF V600 + LDH elevation
    LAG3 expression
    LAG3 overexpression
    PTEN R233X
    PTEN mutation
    PTEN H93D
    PDGFRA G853D
    PDGFRA H845Y
    PDGFRA R841K
    PTEN K128T
    BRAF V600K + LDH elevation
    PDGFRA P577S
    PTEN deletion
    LDH elevation + BRAF mutation
    PTEN P204S
    PDGFRA V658A
    LDH elevation
    LDHB-L + PD-L1 expression
    MUC16 mutation
    BRAF V600 + LDH elevation + PD-L1 negative
    LDHA-L + PD-L1 expression
    RAF1 amplification
    TMB-H + PD-L1 negative
    KIAA1549-BRAF fusion
    TERT amplification
    HER-2 amplification
    CD8 positive
    IDO1 expression
    CD8 overexpression
    HER-2 positive
    CD8 expression
    IDO1 positive
    IDO1 overexpression
    RAF1 R391W
    GNAQ mutation
    GNA11 mutation
    BRAF V600E + CDKN2A deletion + RB1 expression
    BRAF V600K + CDKN2A deletion + RB1 expression
    CTLA4 expression
    IFNG overexpression
    PD-1 expression
    CDKN2A deletion
    CTAG1B overexpression
    PD-1-L
    CTAG1B antibody elevation
    GNA11 Q209L
    CTLA4 overexpression
    CDKN2A exon 2 mutation
    BRAF mutation + MEK1 P124L
    BRAF V600E + MAP2K1 I111S
    IFNG-L
    BRAF mutation + MAP2K1 mutation
    CDKN2A mutation
    PD-1 overexpression
    GNAQ Q209P
    CDKN2A promoter methylation
    CDKN2A deletion
    CD69 overexpression
    TERT promoter mutation + BRAF V600
    MAP2K2 mutation
    COL3A1 mutation
    ERBB4 mutation
    GRIN2A mutation
    PMS2 mutation
    TNFA-L
    IL6 elevation + HGF elevation + CCL8 elevation
    HHLA2 overexpression
    EEF2K overexpression
    IGKC overexpression
    NRAS wild-type + NOTCH4 mutation
    PAPPA2 mutation + TMB-H
    HLA-A2 positive + PMEL overexpression
    TP53 wild-type
    CD8 underexpression + HAVCR2 overexpression
    PAPPA2 mutation
    FAT1 mutation
    CD8 elevation + BRAF V600
    TCF7 overexpression + CD8 overexpression
    GOLGA4-RAF1 fusion
    SORT1 expression
    NTRK2 fusion
    RET mutation
    SERPINB3 mutation
    PIK3CA H1047R
    S100A9 elevation
    CDK4 amplification
    NTRK1 fusion
    NTRK3 fusion
    CMTM6 overexpression + PD-L1 overexpression
    TET1 mutation
    ZKSCAN1-BRAF fusion
    NFKBIE mutation + TMB-H
    PPFIBP2-BRAF fusion
    C7 overexpression
    TPSAB1 expression
    CD9 expression
    CSF2 expression
    STAT2 expression
    C1S overexpression
    SERPINB4 mutation
    IL12RB1 overexpression
    PTCH1 mutation
    AAMP underexpression
    CDKN2A Negative + NRAS Mutation
    CD3D overexpression
    JAML overexpression
    CUL1 underexpression
    CD52 overexpression
    THY1 overexpression
    TIGIT overexpression
    LY9 overexpression
    IRF1 expression
    CCL19 overexpression
    GZMH overexpression
    GZMK overexpression
    AIM2 overexpression
    CD22 overexpression
    TIAM1 overexpression
    S100A8 elevation
    HYDIN mutation
    SETBP1 mutation
    IFNAR1 expression
    NEAT1 overexpression
    CXCL10 elevation
    PD-L2 overexpression
    SLC35A2 overexpression
    HLA-A*02:01
    ICOS overexpression
    NCR3LG1 underexpression + TMB-L
    NCR3LG1 underexpression
    RPTOR mutation
    CCL11 elevation
    CCL2 elevation
    KDR Q472H
    JAK2 underexpression
    VEGFA-L
    TYRP1 antibody elevation
    CD200 underexpression
    CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation
    TRIM33-BRAF fusion
    DCT antibody elevation
    POLE mutation
    MAP2K1 mutation + TMB-H
    MAP2K2 mutation + TMB-H
    MAP3K14 mutation + TMB-H
    IL10-L
    CXCL6-L
    IL23 elevation
    VPS13D mutation
    ALPK2 mutation
    SCUBE1 mutation
    HSPB1 expression
    BTN2A1-H
    TNFRSF9 overexpression
    ADORA2A overexpression
    ADAR overexpression
    MLANA antibody elevation
    BAP1 mutation
    TTN mutation
    CBL mutation
    CARD11 mutation
    NLRC5 overexpression
    PCSK9 underexpression
    SP140 overexpression
    ECM2 mutation
    miR-524-5p overexpression
    MAGEA3 overexpression
    MAGEA4 overexpression
    RPS6KB1 amplification
    MYC amplification
    HRD
    BRAF V600E + PD-L1 expression
    High IFNG gene signature + TMB-H
    RELN mutation
    FGFR3 mutation
    FGFR4 mutation
    PALB2 mutation
    CD27 overexpression
    PTPN11 mutation + TMB-H
    ACSL4 overexpression
    LDHB overexpression
    RECQL5 mutation + TMB-H
    FGFR1 mutation
    FGFR2 mutation
    CD28 overexpression
    CD7 overexpression
    KMT2C mutation
    CD2 overexpression
    KIR3DL2 overexpression
    ENTPD1 overexpression
    MDC1 mutation
    PIK3R1 overexpression
    FSIP2 mutation
    PPL underexpression
    ARID1A mutation
    PPL underexpression + SOX10 underexpression
    ITGAE overexpression
    PRF1 overexpression
    MSI-H/dMMR
    HRAS mutation
    SBK1 overexpression
    IL32 overexpression
    NLRP3 mutation
    GDF15-L
    PD-L1 elevation + CXCL10 elevation + TNFA elevation
    miR-100-5p overexpression
    IFIT3 overexpression
    IFIT1 overexpression
    miR-125b-5p overexpression
    PTPRT mutation
    CRKL mutation
    LYN mutation
    SYK mutation
    PIK3CG mutation
    BRAF mutation + TERT −139CC>TT
    MAP2K2 Q60P
    TP53 deletion
    MAP2K2 C125S
    TYRP1 overexpression
    MAP2K2 L46F
    PIK3CA E545K
    PIK3CA mutation
    GDF15 elevation
    PIK3CG overexpression
    MAP2K2 N126D
    PIK3CG expression
    MAP2K2 V35M
    CARD11 amplification
    BRAF mutation + TERT overexpression
    PIK3CA D350G
    PIK3CA E545G
    TERT mutation + BRAF V600E
    TP53 mutation
    ICOS Methylation
    BRAF mutation + TERT −138CC>TT
    BRAF mutation + TERT −124C>T
    BRAF mutation + TERT −146C>T
    MEK2 F57C
    JAK2 F547
    IFNG gene signature overexpression
    IFNG gene signature
    High IFNG gene signature
    DDR
    TASL expression
    84-gene expression signature
    Choline elevation
    PAK4 overexpression
    MYD88 overexpression
    NARS2 mutation
    CD73 overexpression
    NFKB1 overexpression
    NF1 deletion
    NF1 mutation
    MERTK expression
    HSPA1A elevation
    RAC1 P29S
    STAG2 underexpression
    STAG3 underexpression
    AEBP1 overexpression
    PDGFRB overexpression
    EZH2 Y641F
    EZH2 positive
    EGFR L858R + EGFR T790M
    PD-L1 overexpression + SOX2 overexpression
    MTOR P2213S
    PIK3CD expression
    NF2 deletion
    PRKCH-SPTB fusion
    MTOR H1968Y
    CXCR6 expression + HAVCR2 expression
    TNFRSF1B overexpression
    TNFAIP3 overexpression + BRAF mutation
    EGFR mutation
    BIRC2 amplification
    mTOR amplification
    CD20 positive
    MELTF overexpression
    SESN2 overexpression
    KEAP1 negative
    IL6 elevation
    STING expression
    COL4A5 expression
    IGFBP2 overexpression + PD-L1 overexpression
    SLC31A2 expression
    AKT1 Q79K
    MET overexpression
    PRKCH fusion
    NR2F1 overexpression
    ERBB3 expression
    NRAS G12C + BRAF mutation
    KRAS G13D + BRAF mutation
    RB1 deletion
    EML4-ALK fusion
    MDM2 amplification
    MDM4 amplification
    EGFR amplification
    AKT1 E17K + BRAF V600
    AXL overexpression
    AXL expression
    MTOR S2215Y
    BRAF mutation + NF1 mutation
    AXIN1 deletion
    NRAS mutation + BRAF mutation
    SOX10 underexpression
    CCNE1 amplification
    ARAF mutation + NRAS mutation
    TET2 deletion + DNMT3A mutation
    SF3B1 mutation
    MITF amplification
    NUSAP1 overexpression
    ATXN1L underexpression
    AKT3 E17K
    AGK-BRAF fusion
    AKT1 E17K
    TARDBP-BRAF fusion
    CUL1-BRAF fusion
    SKAP2-BRAF fusion
    FKBP15-BRAF fusion
    BRAF mutation + EGFR mutation
    MAP1LC3B overexpression
    RPS6KA3 overexpression
    JAK1 P429S
    JAK1 Q503*
    MAPK1 overexpression
    TINCR overexpression
    HOXD8 mutation
    PHLPP1 mutation
    miR-19b1 underexpression
    ROR2 overexpression
    NF1 R2450X
    PIK3CD overexpression
    B2M mutation
    PD-1 positive + TIGIT positive + CD8 positive
    BRAF V600E + PTEN deletion
    miR-211 expression
    AURKB overexpression
    IDH1 overexpression
    NRAS mutation + BRAF wild-type
    NRAS Q61K + BRAF V600E
    TRIB3 overexpression
    PRKCH-VWA2 fusion
    USP6 mutation
    HIF1A-PRKCH fusion
    C4G elevation + PRO-C3 underexpression
    STING mutation
    EZH2 Y646
    TCF7L2 deletion
    IFI16 overexpression
    MTAP mutation + CDKN2A mutation
    HLA-DRA expression
    IL18 overexpression
    FCGR2A overexpression
    MAP3K8 overexpression
    IL1RN overexpression
    EZR overexpression + BRAF V600E
    MCAM expression
    TLR5 overexpression
    SEMA6A overexpression + BRAF mutation
    ATM W2845
    HGF elevation
    TLR8 overexpression
    CCL8 elevation